These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10520158)

  • 1. Antifungal activity of cerebrospinal fluid against Cryptococcus neoformans and Candida species.
    Brummer E; Drasin T; Adler JD; Stevens DA
    Med Mycol; 1999 Oct; 37(5):339-44. PubMed ID: 10520158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and characterisation of an anticryptococcal protein in human cerebrospinal fluid.
    Ahluwalia M; Brummer E; Sridhar S; Singh R; Stevens DA
    J Med Microbiol; 2001 Jan; 50(1):83-89. PubMed ID: 11192510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of voriconazole and amphotericin B against Candida albicans, Candida krusei, and Cryptococcus neoformans in human cerebrospinal fluid.
    Al Jalali V; Sauermann R; Eberl S; Zeitlinger M
    Infection; 2019 Aug; 47(4):565-570. PubMed ID: 30725316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of a human serum protein that inhibits the growth of Cryptococcus neoformans.
    Duvvuru S; Brummer E; Morelli R; Stevens DA
    Mycopathologia; 1998-1999; 144(1):1-7. PubMed ID: 10422267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antifungal synergy between amphiphilic aminoglycoside K20 and azoles against Candida species and Cryptococcus neoformans.
    Shrestha SK; Grilley M; Anderson T; Dhiman C; Oblad J; Chang CW; Sorensen KN; Takemoto JY
    Med Mycol; 2015 Nov; 53(8):837-44. PubMed ID: 26260746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of fluconazole minimum inhibitory concentrations in three different formulations of RPMI-1640.
    Espinel-Ingroff A; Steele-Moore L
    Diagn Microbiol Infect Dis; 1994 Oct; 20(2):87-91. PubMed ID: 7867310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
    Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
    Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro activity of dicationic aromatic compounds and fluconazole against Cryptococcus neoformans and Candida spp.
    Del Poeta M; Bixel AS; Barchiesi F; Tidwell RR; Boykin D; Scalise G; Perfect JR
    J Antimicrob Chemother; 1999 Aug; 44(2):223-8. PubMed ID: 10473229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformans.
    Pfaller MA; Messer SA; Hollis RJ; Jones RN
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2862-4. PubMed ID: 11557481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antifungal susceptibility of yeasts by Etest. Comparison of 3 media].
    Tapia C; León E; Palavecino E
    Rev Med Chil; 2003 Mar; 131(3):299-302. PubMed ID: 12790079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotypes of clinical cerebrospinal fluid Cryptococcus neoformans isolates from southern Taiwan and their in vitro susceptibilities to amphotericin B, fluconazole, and voriconazole.
    Chang WN; Huang CR; Lei CB; Lee PY; Chien CC; Chang HW; Chang CS; Lu CH
    Jpn J Infect Dis; 2004 Jun; 57(3):113-5. PubMed ID: 15218221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticryptococcal activity of voriconazole against Cryptococcus neoformans var. gatti vs var. neoformans: comparison with fluconazole and effect of human serum.
    Brummer E; Kamei K; Miyaji M
    Mycopathologia; 1998; 142(1):3-7. PubMed ID: 9850592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.
    Warnock DW; Johnson EM; Rogers TR
    J Antimicrob Chemother; 1998 Sep; 42(3):321-31. PubMed ID: 9786472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of fluvastatin, a cholesterol-lowering agent, and synergy with flucanazole and itraconazole against Candida species and Cryptococcus neoformans.
    Chin NX; Weitzman I; Della-Latta P
    Antimicrob Agents Chemother; 1997 Apr; 41(4):850-2. PubMed ID: 9087504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
    Pfaller MA; Messer SA; Rhomberg PR; Castanheira M
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Berberine Antifungal Activity in Fluconazole-Resistant Pathogenic Yeasts: Action Mechanism Evaluated by Flow Cytometry and Biofilm Growth Inhibition in Candida spp.
    da Silva AR; de Andrade Neto JB; da Silva CR; Campos Rde S; Costa Silva RA; Freitas DD; do Nascimento FB; de Andrade LN; Sampaio LS; Grangeiro TB; Magalhães HI; Cavalcanti BC; de Moraes MO; Nobre Júnior HV
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3551-7. PubMed ID: 27021328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different components in human serum inhibit multiplication of Cryptococcus neoformans and enhance fluconazole activity.
    Nassar F; Brummer E; Stevens DA
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2490-3. PubMed ID: 8585731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.
    Trpković A; Pekmezović M; Barać A; Crnčević Radović L; Arsić Arsenijević V
    J Mycol Med; 2012 Sep; 22(3):243-8. PubMed ID: 23518082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010-2012).
    Pfaller MA; Messer SA; Jones RN; Castanheira M
    J Antibiot (Tokyo); 2015 Sep; 68(9):556-61. PubMed ID: 25899126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A survey of the in vitro antifungal activity of heather (Erica sp.) organic honey.
    Feás X; Estevinho ML
    J Med Food; 2011 Oct; 14(10):1284-8. PubMed ID: 21663476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.